Application of Molecular Imaging for Drug Discovery and Development in Hematology Research
Book:
Frontiers in Clinical Drug Research: Hematology
Page:
179-224
Author(s):
Pengfei Xu, Min Liu, Xiaobo Wang, Zhiguo Liu, Weimin Miao and Wenbin Zeng
Thalidomide, Bortezomib and Lenalidomide – Three Drugs that Changed Multiple Myeloma
Book:
Frontiers in Clinical Drug Research: Hematology
Page:
103-178
Author(s):
Jiri Minarik and Vlastimil Scudla
Myeloproliferative Neoplasms – Molecular Biology and Potential Targets for Intervention
Book:
Frontiers in Clinical Drug Research: Hematology
Page:
62-102
Author(s):
Martin H. Bonamino, Barbara Monte-Mor, Cristiana Solza and Ilana Zalcberg
Epigenetic Drugs in Myelodysplastic Syndrome and the Leukemias
Book:
Frontiers in Clinical Drug Research: Hematology
Page:
42-61
Author(s):
Jacob Peedicayil
Is a Protective Microenvironment the “Achille’s Heel” in Chronic Lymphocytic Leukemia?
Book:
Frontiers in Clinical Drug Research: Hematology
Page:
3-41
Author(s):
Paolo Giannoni and Daniela de Totero
List of Contributors
Book:
Frontiers in Clinical Drug Research: Hematology
Page:
iii-iv
Author(s):
Atta-ur-Rahman
Preface
Book:
Frontiers in Clinical Drug Research: Hematology
Page:
i-ii
Author(s):
Atta-ur-Rahman
Subject Index
Book:
Cutting Edge Therapies for Cancer in the 21st Century
Page:
513-519
Author(s):
Pier Paolo Claudio and Paraskevi Vogiatzi
Ultrasound Contrast Agents in Cancer Therapy
Book:
Cutting Edge Therapies for Cancer in the 21st Century
Page:
425-512
Author(s):
Rounak Nande and Pier Paolo Claudio
Cancer Therapy May be Improved if Diet Contains Omega 3 Fatty Acids
Book:
Cutting Edge Therapies for Cancer in the 21st Century
Page:
387-424
Author(s):
Johannes F. Fahrmann, Theodore R. Witte and W. Elaine Hardman